EXECUTIVE SUMMARY
Female genital mutilation (FGM) is a deeply entrenched practice affecting an estimated 230 million girls and women alive today, concentrated in 30 countries across sub-Saharan Africa and the Middle East, with diaspora communities in Europe, North America, and Australia. It is classified as a human rights violation and a form of gender-based violence with no medical justification, causing immediate physical harm, long-term reproductive health consequences, and psychological trauma. Despite decades of advocacy, the absolute number of girls at risk globally has not declined — largely because population growth in high-prevalence countries is outpacing the rate of prevalence decline.
The primary multilateral response is the UNFPA-UNICEF Joint Programme on the Elimination of FGM, branded "Accelerating Change," which has operated in successive phases since 2008 across 17 priority countries. The programme's dominant model is community-led social norm change — rooted in the theoretical insight that FGM persists through collective social expectation rather than individual belief, meaning change requires coordinated community agreement rather than individual persuasion. This approach has stronger evidence behind it than legal enforcement alone, particularly from Senegal's experience with the Tostan model.
Evidence of programme impact is uneven. Population-level prevalence data from Demographic and Health Surveys confirms declining rates among younger cohorts in most programme countries — a genuine and significant trend. However, attribution to the joint programme specifically is methodologically difficult, and programme evaluations have found that community abandonment declarations do not consistently translate into documented behaviour change. The hardest evidence comes from Senegal and Ethiopia; evidence from other country contexts is thinner. The medicalisation of FGM — where cutting is performed by health professionals rather than traditional practitioners — represents an emerging challenge that the community abandonment approach does not directly address.
The 2030 SDG target of eliminating FGM is widely acknowledged to be unreachable at current rates. Structural factors — population growth, the intensive cost of the community-based model, hard-to-reach nomadic and conflict-affected populations — mean that even with full implementation of current programme approaches, elimination within this generation is unlikely in the highest-burden countries. This document provides a comprehensive analysis for practitioners designing or implementing FGM programmes, for funders assessing return on investment, and for researchers evaluating the evidence base.
KEY FACTS
- An estimated 230 million girls and women alive today have undergone FGM — revised upward from earlier 200 million estimates based on improved measurement (UNICEF 2024 data).
- Approximately 4.3 million girls are at risk of FGM each year, with the majority in sub-Saharan Africa.
- FGM is practiced in at least 30 countries, predominantly in a band from Senegal in the west to Somalia and Ethiopia in the east, plus parts of the Middle East (Egypt, Iraq, Yemen) and diaspora populations worldwide.
- The highest prevalence countries are Somalia (~99%), Guinea (~97%), Djibouti (~90%), and Sierra Leone (~86%) — based on most recent DHS/MICS data.
- The global rate among girls aged 15–19 has declined across most programme countries, suggesting generational trend improvement, but absolute numbers are not falling due to population growth.
- The UNFPA-UNICEF Joint Programme "Accelerating Change" has operated since 2008; the current phase (Phase IV) runs to 2030, funded primarily by the European Union, with additional support from Norway, Sweden, Italy, and others.
- The programme operates in 17 priority countries: Burkina Faso, Djibouti, Egypt, Ethiopia, Eritrea, The Gambia, Guinea, Guinea-Bissau, Kenya, Mali, Mauritania, Nigeria, Senegal, Sierra Leone, Somalia, Sudan, and Uganda.
- Cumulative joint programme results through Phase III (2018–2023): over 40 million people engaged in community dialogues, over 15,000 communities making collective abandonment declarations, over 250,000 health workers trained on FGM complications management.
- The Tostan model — a community empowerment programme in Senegal — is the most rigorously evaluated abandonment model. A 2008 evaluation by Diop et al. found a 72% reduction in FGM in communities completing the programme versus controls, with effects sustained over follow-up.
- WHO recognises four types of FGM; Type III (infibulation) is the most severe and most prevalent in Somalia, Sudan, and Djibouti; Types I and II predominate across West Africa.
- FGM increases the risk of obstetric complications: WHO's 2006 prospective study across six African countries found women with FGM had a 15–55% increased risk of caesarean section and perinatal mortality compared to women without FGM.
- The medicalisation of FGM is rising: UNICEF data from Egypt shows approximately 38% of FGM is now performed by health professionals; similar trends are observed in Kenya, Nigeria, and Sudan.
- UN modelling published in 2023 estimates that at current rates of decline, global elimination of FGM will not be achieved until after 2120 — nearly a century past the 2030 SDG target.
- Legal prohibition of FGM exists in 26 of 30 high-prevalence countries, but prosecution rates remain extremely low — fewer than 30 documented prosecutions across all countries in any given year.
- UNFPA estimates that achieving 30x acceleration in progress (the rate needed to end FGM by 2030) would require approximately USD 2.9 billion in additional programme investment.
- In the context of diaspora communities, an estimated 600,000 women living in Europe have undergone FGM; prevalence among daughters of migrants is lower but not zero, indicating the practice continues in diaspora contexts.
BACKGROUND AND CONTEXT
What FGM Is and Why It Persists
FGM encompasses all procedures involving partial or total removal of the external female genitalia, or other injury to the female genital organs, for non-medical reasons (WHO definition). The four WHO-classified types reflect the range of procedures:
- Type I (Clitoridectomy): Partial or total removal of the clitoris and/or the prepuce. The most common type in some West African countries.
- Type II (Excision): Partial or total removal of the clitoris and inner labia, with or without excision of the outer labia. Predominant in Nigeria, Ethiopia, and parts of West Africa.
- Type III (Infibulation): Narrowing of the vaginal opening through the creation of a covering seal. The most severe form, most common in Somalia, Djibouti, Eritrea, and parts of Sudan.
- Type IV: All other harmful procedures including pricking, piercing, incising, scraping, and cauterising the genital area.
The persistence of FGM cannot be explained by simple models of coercion or ignorance. Anthropological and sociological research — particularly the work of Bettina Shell-Duncan and Ylva Hernlund — has established that FGM functions primarily as a social norm: a shared standard of behaviour, backed by social sanctions and expectations of social rewards. Families in communities where FGM is practiced may privately hold negative views of the practice but feel compelled to have daughters cut because the social consequences of not doing so — unmarriageability, social exclusion, community stigma — are perceived as more damaging than the health risks of the procedure.
This social norm framing has profound implications for programme design. It means individual-level education and persuasion are insufficient if no change in community-wide expectation occurs. A family that changes its own view of FGM will not change its behaviour until it believes enough other families have also changed — or until a coordinated collective agreement not to practice has been established. This is the theoretical foundation of the abandonment approach.
Geographic and Demographic Burden
The geographic concentration of FGM has remained broadly stable for decades. Sub-Saharan Africa accounts for the vast majority of cases globally. West Africa (Guinea, Sierra Leone, Mali, Burkina Faso, Senegal, The Gambia) has high prevalence and large populations. The Horn of Africa (Somalia, Ethiopia, Eritrea, Djibouti) has the highest absolute prevalence rates. Egypt is by far the most populous high-prevalence country, with approximately 27 million affected women — the largest national total globally. Nigeria has significant absolute numbers despite lower national prevalence figures, due to wide regional variation (northern and some southern states have high prevalence; southwestern states very low).
The intersection of high fertility, population growth, and persisting FGM creates a compound challenge: even if the proportion of girls being cut each year declines, the absolute number may rise. The Population Reference Bureau estimated in 2023 that by 2030, the number of girls at risk of FGM per year could reach 4.6 million — higher than today — if current demographic trends continue alongside current rates of prevalence change.
Historical Development of the Joint Programme
International attention to FGM as a public health and human rights issue dates to the 1970s–80s, when African feminist scholars and health advocates began bringing the issue to international forums. The 1994 ICPD Programme of Action included explicit language calling for the elimination of FGM. WHO, UNICEF, and UNFPA issued a joint statement against FGM in 1997.
UNFPA and UNICEF launched their first joint programme on FGM in 2008 (Phase I, 2008–2013), following earlier uncoordinated country-level activities. The joint programme structure was designed to combine UNFPA's strength in reproductive health and community engagement with UNICEF's strength in child protection and government system engagement. Subsequent phases (Phase II 2014–2017, Phase III 2018–2023, Phase IV 2024–2030) have progressively expanded country coverage, increased programme integration, and refined the community-based model.
WHAT UNFPA DOES: PROGRAMME DETAIL
The Community-Based Abandonment Approach
The joint programme's primary operational model is community-led social norm change, implemented through a structured process of community engagement. The process typically takes two to four years per community and involves:
Mapping and entry: Community mapping to identify key influencers (traditional leaders, religious leaders, women's group leaders, school teachers) and existing attitudes toward FGM. Consent for programme entry from community leadership is required.
Community dialogue facilitation: A series of facilitated conversations — separately with women and girls, men and boys, mixed groups, and key influencer groups — to surface existing attitudes, discuss health consequences, and explore the social norms that sustain FGM. Trained community facilitators (often drawn from within the community) lead these dialogues. Dialogue content covers: health consequences of FGM (specifically, long-term complications and obstetric risks); rights-based framing of bodily autonomy; the social norm mechanism (helping community members see how collective expectations, rather than individual belief, perpetuate the practice); religious authority analysis (engaging Islamic scholars on the lack of religious sanction for FGM); and exploration of alternative rites of passage.
Alternative Rite of Passage (ARP) development: In communities with strong ritual significance attached to the cutting ceremony, the programme supports development of alternative initiation rites that preserve cultural meaning — celebrating girls' transition to womanhood — without cutting. This approach has been used extensively in Kenya (notably among Meru communities by the organisation Maendeleo ya Wanawake) and in parts of Ethiopia.
Public collective abandonment declarations: Communities that have reached consensus through dialogue make a public declaration that they will end FGM. The public character of the declaration is critical — it functions as a credible commitment mechanism, broadcasting to the community that the social contract has changed. UNFPA and UNICEF facilitate but do not script these declarations; their content and form vary by community context.
Post-declaration follow-up: Monitoring visits after the declaration to assess whether behaviour has changed, to provide reinforcement and support, and to address backsliding. This is an acknowledged programme weakness — follow-up support is often insufficient and community monitoring of actual practice change is limited.
Integration with the Health System
UNFPA's comparative advantage within the joint programme includes working with health providers on:
- Training health workers to manage FGM complications — particularly for obstetric complications and de-infibulation for labour.
- Advocacy against medicalisation: Engaging professional medical associations (obstetric societies, nursing councils) to adopt and enforce ethical standards prohibiting health professionals from performing FGM.
- Strengthening FGM clinical management guidelines: Supporting ministries of health to develop clinical protocols for managing FGM complications, including protocols for survivors presenting for antenatal care, labour, and gynaecological services.
- Psychosocial support integration: Training health workers in trauma-informed care for FGM survivors and linking FGM response to GBV referral pathways.
Legal and Policy Advocacy
The joint programme supports legal and policy frameworks through:
- Technical support for drafting and passage of legislation criminalising FGM in countries that lack it.
- Training of judicial staff, police, and social workers on FGM law enforcement and survivor support.
- Advocacy for national FGM action plans, including costed implementation frameworks.
- Engagement with diaspora communities and receiving-country governments on the issue of FGM in diaspora contexts (working with European governments on frameworks for girls at risk in diaspora communities).
Data and Measurement
The joint programme has invested in improving FGM data — both to understand the problem and to monitor programme impact:
- Supporting DHS and MICS survey rounds to include FGM modules.
- The "Countdown to Zero" tracking framework monitors prevalence trends and programme coverage across 17 priority countries.
- Supporting national FGM surveys where DHS data is unavailable or outdated.
- Research on medicalisation trends and on FGM among diaspora populations.
THE EVIDENCE BASE
Evidence on the Community Abandonment Model
The Tostan Senegal evaluation (Diop et al., 2004, 2008): The most rigorously evaluated community abandonment programme. Tostan's three-year Community Empowerment Programme in Senegal — covering human rights, problem-solving, health, and hygiene — was associated with a 72% reduction in FGM in participating communities compared to matched controls. A follow-up study found effects were sustained up to ten years post-intervention. Methodological quality: moderate-to-strong for an intervention of this type. The study uses a matched comparison design rather than a randomised controlled trial; confounding cannot be fully excluded. The evaluation has been replicated and independently reviewed and is widely regarded as credible evidence of impact.
Evaluations from other country contexts: The evidence picture is more mixed outside Senegal. A 2018 independent evaluation of the joint programme's Phase II (commissioned by UNFPA/UNICEF but conducted by independent evaluators) found significant variation across countries: strong evidence of attitude change and increased awareness in most countries; moderate evidence of community abandonment declarations; weaker evidence of actual behaviour change (whether girls in post-declaration communities were not cut). This pattern — attitude changes leading declarations, declarations not consistently translating into practice change — is the central evidentiary concern.
The Ethiopia experience: Ethiopia has shown one of the stronger trajectories. National DHS data shows the prevalence of FGM among women aged 15–49 declining from 74% in 2000 to approximately 55% in 2016, with the declining trend steeper among younger cohorts. UNFPA- and UNICEF-supported community programmes in Afar, Amhara, Oromia, and SNNPR regions have been associated with programme-area improvements. Methodological caveats: the trend predates the joint programme in some regions; and government and NGO activities operating alongside the joint programme make attribution difficult.
Alternative Rite of Passage (ARP) evidence: A systematic review by Oloo et al. (2011, published in Culture, Health and Sexuality) assessed ARP programmes across Kenya, Tanzania, Uganda, and Ethiopia. The review found that ARPs can successfully reduce FGM among participating girls and families, but that: (a) ARPs require sustained community ownership and engagement to be maintained; (b) ARPs that are perceived as externally imposed lose community legitimacy; and (c) the durability of ARP-based norm change across generations has not been well demonstrated. Quality of evidence: weak-to-moderate due to lack of controlled comparison groups and short follow-up periods.
Evidence Quality Assessment (GRADE-Style)
- Community abandonment approach (Tostan model) reducing FGM prevalence in Senegal: Moderate evidence. The Tostan evidence is the strongest available for any FGM abandonment programme and should be treated as the best-available-evidence model.
- Community abandonment approach in other country contexts: Weak evidence. Programme evaluations show attitude change; behaviour change evidence is inconsistent and often based on self-report.
- Legal enforcement reducing FGM: Very weak evidence. No rigorous evaluation demonstrates that criminalisation alone reduces FGM prevalence. Studies from Ethiopia (Asefa and Bhardwaj, 2009) and Kenya suggest criminalisation may drive practices underground rather than eliminate them.
- Health worker training reducing medicalisation: Very weak evidence. Training programmes exist; no rigorous evaluations of whether training changes health worker behaviour at scale.
- ARP approaches: Weak evidence. ARP evaluations show short-term effect among direct participants; durability and scaling evidence is lacking.
Key Contested Finding: Does Attitude Change Lead to Behaviour Change?
The joint programme's theory of change assumes that community dialogue leading to changed attitudes about FGM will eventually produce changed behaviour (fewer girls cut). This assumption is theoretically grounded in the social norm model: if enough community members publicly commit, social expectations shift and behaviour follows. However, a persistent finding across evaluations — and a major debate in the academic literature — is whether attitude change measured in programme evaluations translates into actual practice change.
Shell-Duncan et al. (2011, Studies in Family Planning) analysed survey data from Senegal and found that a significant proportion of women who expressed support for FGM abandonment still intended to have daughters cut — demonstrating that attitude change and behavioural intention change are not the same thing. This finding does not invalidate the community abandonment approach, but it underscores that attitude measurement is a leading indicator, not an outcome.
Evidence on Health Consequences
Health consequence evidence is strong and consistent. The WHO multi-country study (2006), covering 28,393 women across six African countries, is the largest and most rigorous study of FGM's obstetric consequences. Key findings: women with FGM had significantly higher rates of obstetric complications including prolonged labour, postpartum haemorrhage, caesarean section, infant resuscitation, and perinatal death. Type III FGM had the most severe effects. This study established the obstetric case against FGM definitively; its findings have been confirmed in subsequent country-level studies.
IMPLEMENTATION REALITIES
What the Programme Looks Like in Practice
Community-based FGM programmes are resource-intensive and slow. A single community engagement process requires: trained facilitators (ideally from within or near the community); logistics for multiple community meetings over two to four years; follow-up monitoring capacity; and engagement with religious and traditional leadership. The cost per community varies significantly by country context and implementation organisation, but UNFPA estimates suggest averages of USD 10,000–30,000 per community engagement process, depending on remoteness and community size. With tens of thousands of communities requiring engagement across 17 countries, the funding requirements for full-scale implementation dwarf current programme budgets.
Common Failure Modes
Surface declarations without sustained follow-up: The most frequently documented failure mode in country evaluations is that communities make abandonment declarations — often at public ceremonies with programme staff in attendance — but the follow-up monitoring needed to assess and reinforce actual practice change is not sustained. Country offices and implementing partners rarely have the resources for multi-year post-declaration monitoring. The result is declarations on paper that may or may not reflect actual change.
Elite capture of dialogue processes: Community dialogues convened in formal settings sometimes surface the views of dominant community members (older men, traditional leaders) rather than those of women and girls most directly affected. Women and girls may express agreement in mixed settings but behave differently in private. Facilitator skill in creating genuinely safe spaces for girls' voices is critical and highly variable.
Backlash and secrecy: Legal criminalisation, while poorly enforced, has in some contexts driven FGM underground — with cutting performed younger (to reduce detection), in secret locations, and without communication to health services. This "clandestine FGM" is harder to reach with programme activities and harder to measure in surveys (under-reporting in surveys increases when the practice is illegal or stigmatised).
Medicalisation as harm reduction without abandonment: A significant and growing challenge. In Egypt, where FGM is illegal and heavily stigmatised, approximately 38% of procedures are performed by physicians or nurses, often framed as a "safe" reduced procedure. Community education that FGM is dangerous has in some contexts produced a demand for "safer" medicalised versions rather than abandonment. The joint programme has invested in engaging medical professional associations, but changing professional norms alongside community norms is a double challenge.
Staff turnover and capacity: Implementing partner organisations carrying out community engagement work face high staff turnover, particularly for the best-trained community facilitators who are attractive for other employment. Loss of experienced facilitation capacity undermines programme quality and requires continuous re-investment in training.
Country Examples
Senegal: The strongest programme context, with the longest programme history. Tostan has operated in Senegal since the early 1990s; the joint programme built on this foundation. National DHS data shows a significant generational decline: prevalence among 15–19 year olds is approximately half that of women over 45. Programme coverage, however, remains incomplete — remote rural communities and specific ethnic groups (particularly communities in eastern Senegal) have seen less change.
Somalia: The most challenging programme context. Prevalence remains at approximately 99%. The combination of armed conflict, extremely high prevalence, Type III predominance, and deep cultural entrenchment means that the community abandonment model faces structural barriers. The joint programme has maintained a presence in accessible parts of Somalia but scale of reach is limited relative to need.
Kenya: A varied picture. National prevalence has declined significantly — from approximately 32% in 1998 to approximately 21% by the mid-2010s, with further decline in most recent surveys. The Maendeleo ya Wanawake ARP approach has shown impact in some communities. However, prevalence among specific ethnic groups (Somali, Kuria, Maasai) remains extremely high, and national-level trend data masks deep sub-national variation.
FUNDING, SCALE AND RESOURCES
Budget Overview
The UNFPA-UNICEF Joint Programme is funded through a dedicated trust fund, with contributions from bilateral donors. The European Union has been the primary donor, contributing approximately EUR 46 million for Phase III (2018–2023), representing roughly 60% of total programme funding. Norway, Sweden, Italy, and the United Kingdom have contributed the remainder in varying proportions across phases.
Total cumulative funding across all phases (2008–2023) is approximately USD 300 million. This represents the primary multilateral investment in FGM elimination globally, though bilateral NGO programmes (particularly Tostan, Plan International, and 28 Too Many's country affiliates) operate alongside and sometimes in partnership with the joint programme.
Cost-Effectiveness Analysis
No comprehensive, peer-reviewed cost-effectiveness analysis of the FGM joint programme has been published. Programme-level cost data exists within UNFPA/UNICEF internal documents but has not been subjected to rigorous comparative analysis. The World Bank's 2020 analysis of the economic costs of FGM — estimating lifetime economic costs from FGM-related medical complications at approximately USD 1.4 billion per year globally — provides a theoretical frame for cost-benefit analysis of prevention investment, but mapping this to specific programme investments requires assumptions that current evidence does not support.
What can be stated: UNFPA's modelling suggests that scaling up the programme to achieve 30x acceleration (the rate needed to eliminate FGM by 2030) would require approximately USD 2.9 billion in additional investment — orders of magnitude above current funding levels. This figure has been used in advocacy for increased donor commitment.
UNFPA's Specific Financial Contribution
Within the joint programme budget, UNFPA and UNICEF typically split programme management and implementation responsibility roughly equally. UNFPA's total annual expenditure on FGM (including joint programme share plus country office contributions) is approximately USD 20–30 million per year — a relatively small proportion of UNFPA's total programme expenditure, reflecting the specialist nature of this programme area.
KEY DEBATES AND CONTESTED QUESTIONS
1. Is the Community Abandonment Model the Right Primary Approach?
The joint programme's dominant model has been criticised from two directions. From the rights side: critics argue that the abandonment approach's emphasis on community consensus may inadvertently legitimise communities' claimed right to "decide" about girls' bodily integrity, rather than framing FGM as an unconditional violation regardless of community consensus. From the evidence side: critics argue that the evidence for scaling the community abandonment model beyond Senegal's specific context is insufficient to justify its primacy as the global approach.
The counter-arguments: alternative approaches (legal enforcement, media campaigns) have weaker evidence; the social norm framing is well-grounded in theory and the Senegal evidence; and the rights critique, while valid, does not generate a more effective programmatic alternative.
2. Should Legal Enforcement Be Prioritised More?
The current balance in the joint programme leans heavily toward community-based approaches, with legal frameworks treated as enabling conditions rather than primary drivers. A minority view — more prominent in some civil society organisations than within the UN system — argues that stronger enforcement of existing laws would accelerate decline. The counter-evidence from Ethiopia and Kenya suggests that enforcement-heavy approaches drive the practice underground rather than eliminating it, and may deter girls from seeking medical care for complications.
3. How to Respond to Medicalisation
The rise of medicalised FGM poses a fundamental dilemma: FGM performed by health professionals in hygienic conditions is physically safer than cutting performed by traditional practitioners, but it represents continuation of a rights-violating practice. The WHO, UNFPA, and UNICEF position is clear — medicalisation is not acceptable and health professionals should not perform FGM regardless of clinical safety considerations. But programme responses to medicalisation (professional association engagement, regulatory enforcement) are weak relative to the scale of the trend. Some researchers have argued that harm reduction approaches (accepting that some FGM will persist, focusing on reducing severity and complications) are more realistic than elimination approaches; this is strongly resisted by mainstream UN system and human rights advocacy.
4. Attribution and the Programme's Counterfactual
A persistent methodological debate concerns what would have happened without the joint programme. Prevalence trends are declining in most programme countries — but prevalence was declining in some countries before the programme started, and declining in countries without the programme. This makes it difficult to determine what proportion of observed change is attributable to the joint programme versus broader social change, urbanisation, education, economic development, or other factors. The honest assessment is that the joint programme is likely contributing to accelerated change in countries where it operates, but the magnitude of its specific contribution cannot be precisely quantified with current evidence.
IMPLICATIONS BY AUDIENCE
For Frontline Staff and Practitioners
The most important operational principle is patience and depth over speed and breadth. The social norm change model requires sustained, multi-year engagement with specific communities. Shortcuts — rapid community dialogues, ceremony-only declarations, single-visit interventions — do not produce durable change and may create false evidence of progress. Quality facilitation is the single most important programme input; invest heavily in facilitator selection, training, and supervision.
For clinical staff: all women and girls presenting to health services in high-prevalence contexts should be routinely screened for FGM, with appropriate documentation, counselling, and clinical management. De-infibulation should be available at every facility with maternity services in high-prevalence areas. FGM complications management should be integrated into pre-service midwifery and nursing curricula, not delivered only as supplementary training.
Practitioners working in communities with high medicalisation rates should coordinate with district health offices and medical professional associations — community behaviour change without parallel professional norm change will not reduce medicalisation.
For practitioners working with diaspora communities: cultural sensitivity does not require permissiveness. Girls at risk in diaspora contexts should be identified through school, health service, and community contacts; child protection referral pathways should be clearly established and followed.
For Programme Managers and Decision-Makers
Resist pressure to report progress primarily through output metrics (community dialogues conducted, declarations made) while evidence of actual behaviour change is limited. Results frameworks should include prevalence data from repeat surveys in programme communities — not just national DHS data, which cannot capture community-level programme impact. Where survey data shows attitude change without behaviour change, this should be reported honestly and programme design should respond.
Coordinate closely with government counterparts to address the two most under-funded aspects of FGM programming: post-declaration follow-up monitoring, and clinical management of FGM complications in health facilities. These are less visible than community dialogue activities but are critical to programme quality.
For Donors and Board Directors
The case for continued investment in the joint programme is grounded in: (a) the programme has the strongest evidence base of any multilateral FGM intervention; (b) the issue will not resolve without sustained external investment — no country with high FGM prevalence has eliminated the practice without sustained external programme support; and (c) the health and rights consequences are severe and well-documented.
However, donors should apply scrutiny to two specific areas: (a) whether funded community engagement is sufficiently deep and followed up to produce genuine behaviour change rather than declarations; and (b) whether rising medicalisation is being adequately addressed within current programme design. The most productive donor contribution — beyond financial support — is sustained multi-year funding commitments. The community abandonment model requires programme continuity over three to seven year horizons; annual funding cycles and short-term commitments undermine programme effectiveness.
The 2030 SDG target is unreachable at current investment levels. Honest engagement with this reality is more useful than maintaining the target as an aspirational rhetoric. A more credible commitment would be to specific, country-level prevalence targets over a ten-year horizon, supported by country-specific costed programme plans.
For Researchers
The most significant research gaps in the FGM evidence base are:
- Rigorous evaluation of community abandonment outside Senegal: Most evaluations in other country contexts are programme monitoring exercises rather than independent evaluations with credible comparison groups. Quasi-experimental designs (difference-in-difference, regression discontinuity, or matched comparison) applied consistently across multiple programme contexts would substantially strengthen the evidence.
- Longitudinal behaviour change measurement: The gap between attitude change and behaviour change is the central evidentiary problem. Longitudinal household surveys tracking girls over time (following cohorts from pre-programme through adolescence in both programme and comparison communities) would provide the most valuable evidence.
- Medicalisation dynamics: The drivers of medicalisation — community demand versus provider supply; economic incentives; legal environment — are poorly understood. Mixed-method research combining quantitative surveys with qualitative investigation of provider motivations would inform programme design.
- Diaspora FGM: The evidence base on FGM in diaspora communities (prevalence, drivers, programme effectiveness) remains thin. Improved measurement in European and North American contexts, and evaluation of diaspora-specific programme models, is a significant gap.
- Cost-effectiveness: No published peer-reviewed cost-effectiveness analysis of FGM prevention programmes exists. Given the large financing requirements, this is a critical gap for donor decision-making.
CURRENT STATUS AND FUTURE DIRECTIONS
The joint programme's Phase IV (2024–2030) operates under an environment of increasing global awareness of FGM as a rights and health issue, but also increasing pressure from political actors in some high-prevalence countries who frame external FGM elimination advocacy as cultural imperialism. The programme's response to this tension — emphasising community ownership and cultural dialogue while maintaining the non-negotiable rights position that FGM is a violation — is the correct balance but requires sophisticated facilitation at country level.
UNFPA and UNICEF are piloting digital approaches to reach communities where in-person engagement is constrained — using social media, SMS platforms, and online community dialogue tools. These have shown promise in urban contexts and diaspora communities but cannot substitute for in-person community engagement in rural high-prevalence settings.
The fiscal environment for Phase IV is constrained by reductions in EU development spending and competing humanitarian funding demands. Without equivalent or greater funding from other bilateral donors, Phase IV risks scaling back rather than accelerating.
SOURCES
Shell-Duncan B, Hernlund Y (eds) (2000): Female "Circumcision" in Africa: Culture, Controversy and Change. Lynne Rienner. The foundational anthropological collection; provides the theoretical grounding for the social norm approach and documents cultural variation across countries. Essential reading for understanding why community-based approaches are necessary.
Diop NJ et al. (2004, 2008): Tostan programme evaluations from Senegal. The strongest available empirical evidence for the community abandonment model. Documents a 72% reduction in FGM in programme communities versus controls. Available through the Population Council and Tostan research publications.
WHO (2006): Elimination of Female Genital Mutilation: Report of a WHO Technical Consultation. Includes the large multi-country prospective study on obstetric consequences of FGM across six African countries — the definitive health consequence evidence.
Shell-Duncan B et al. (2011): "Dynamics of Change in the Practice of Female Genital Cutting in Senegambia." Studies in Family Planning. Documents the attitude-behaviour gap — a critical finding for programme designers.
UNICEF (2024): Female Genital Mutilation — Global and Regional Estimates. The primary global prevalence data source, with country-level breakdowns and generational trend analysis.
UNFPA-UNICEF Joint Programme (2023): Accelerating Change Phase III End of Phase Report. Summarises cumulative programme results, independent evaluation findings, and lessons for Phase IV design.
Oloo H et al. (2011): "An Analysis of Practising and Non-Practising Communities' Perspectives on Abandonment of Female Genital Mutilation." Culture, Health and Sexuality. Systematic review of alternative rite of passage approaches; weak-to-moderate quality evidence.
WHO (2020): Care of Girls and Women Living with Female Genital Mutilation: A Clinical Handbook. Practical clinical guidance for health workers managing FGM complications; essential for clinical training programmes.
Mackie G, LeJeune J (2009): "Social Dynamics of Abandonment of Harmful Practices." Innocenti Working Paper. Theoretical elaboration of the social convention model applied to FGM; foundational for programme theory of change.
Population Reference Bureau (2023): The Potential Demographic Impact on FGM Elimination Goals. Quantifies the population growth challenge to achieving 2030 targets.
RELATED DOCUMENTS
- UNFPA-O-02: Three transformative results (harmful practices component)
- UNFPA-W-05: GBV in humanitarian settings (FGM in crisis contexts)
- UNFPA-W-07: Child marriage (overlapping harmful practices agenda)
- UNFPA-C-04: Where UNFPA's results are disputed
- UNFPA-O-07: UNFPA in the wider SRHR architecture (UNICEF partnership)